市場調查報告書
商品編碼
1029103

氣喘治療藥的全球市場 (2021-2026年):產業趨勢、市場佔有率、市場規模、成長預測、市場機會

Asthma Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日期: | 出版商: IMARC Services Private Limited | 英文 147 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球氣喘治療藥的市場規模在預測期間內預計以1.60%的年複合成長率發展,從2020年的176億美元,成長到2026年191億3000萬美元的規模。

氣喘為首的呼吸疾病增加和診斷技術的提高是促進該市場成長的重要要素之一。還有一般消費者對有效的氣喘治療藥的意識高漲也成為市場成長的原動力。再加上呼吸疾病治療的聯合治療的開發,醫療費增加,醫學領域的廣泛R&D活動,醫療基礎設施的改善等要素也預計是慮市場更加活化的要素之一。

本報告提供全球氣喘治療藥的市場調查,市場定義和概要,價值鏈,新型冠狀病毒感染疾病 (COVID-19)以及其他的市場影響因素分析,市場規模的變化、預測,醫藥品分類、產品類型、治療區分、給藥途徑、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

目錄

第1章 序文

第2章 調查範圍、調查手法

第3章 摘要整理

第4章 簡介

第5章 世界市場趨勢

  • 市場概要
  • 市場成果
  • COVID-19的影響

第6章 市場分析、預測:各醫藥品分類

  • 抗發炎藥
  • 支氣管擴張藥
  • 並用藥

第7章 市場分析、預測:各產品類型

  • 吸入器
  • 噴霧器

第8章 市場分析、預測:各治療種類

  • 速效藥
  • 長期控製藥

第9章 市場分析、預測:各給藥途徑

  • 吸入
  • 口服
  • 非口服

第10章 市場分析、預測:各地區、主要國家

  • 北美
  • 亞太地區
  • 歐洲
  • 南美
  • 中東、非洲

第11章 SWOT分析

第12章 價值鏈分析

第13章 波特的五力分析

第14章 價格分析

第15章 競爭情形

  • 市場結構
  • 主要企業
  • 主要企業的簡介
    • AstraZeneca
    • Abbott
    • Amgen Inc.
    • Biogen Inc.
    • Boehringer Ingelheim GmbH
    • F. Hoffmann-La Roche AG
    • GlaxoSmithKline Plc.
    • Merck & Co. Inc.
    • Novartis AG
    • Sunovion Pharmaceuticals Inc.(Dainippon Sumitomo Pharma Co. Ltd.)
    • Teva Pharmaceutical Industries Ltd.
目錄
Product Code: SR1020F53_Report

The global asthma therapeutics market reached a value of US$ 17.6 Billion in 2020. Looking forward, the market is expected to reach a value of US$ 19.13 Billion by 2026, expanding at a CAGR of 1.60% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor. Asthma therapeutics refer to various pharmaceutical drugs that are used for the treatment of asthma. Asthma is usually triggered by indoor and outdoor causative agents, including pollution, allergens and dust. These therapeutics are usually bronchodilators and anti-inflammatory drugs, which include corticosteroids, long-acting beta-agonists (LABA), methylxanthine, immunomodulators and leukotriene modifiers. A number of combination therapy drugs are also used that can be inhaled, injected, or orally administered. These drugs expand the passageway into the lungs and enable the movement of air to improve breathing. They also aid in clearing mucus from the lungs that gets coughed out with ease.

Global Asthma Therapeutics Market Trends and Drivers:

  • The increasing prevalence of asthma and other respiratory disorders, along with improvements in the diagnostic technologies, is one of the key factors driving the growth of the market. Furthermore, rising awareness among the masses regarding the availability of effective asthma therapeutics is also providing driving the market growth. For instance, asthmatic patients are primarily treated with inhaled corticosteroids and patients with advanced conditions or persistent asthma are treated with target-specific drugs. There is also an extensive demand for monoclonal antibodies (mAbs) that block immunoglobulin E and specific cytokines. The development of combination therapies for the treatment of respiratory diseases is acting as another growth-inducing factor. Increasing healthcare expenditures, extensive research, and development (R&D) activities in the field of medical sciences and improvements in the healthcare infrastructure are some of the other factors that are expected to drive the market further.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global asthma therapeutics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on drug class, product type, treatment type, route of administration and region.

Breakup by Drug Class:

  • Anti-Inflammatory Drugs
  • Bronchodilators
  • Combination Therapies

Breakup by Product Type:

  • Inhalers
  • Dry Powder Inhalers
  • Metered Dose Inhalers
  • Soft Mist Inhalers
  • Nebulizers
  • Pneumatic Nebulizers
  • Ultrasonic Nebulizers
  • Mesh Nebulizers

Breakup by Treatment Type:

  • Quick-Relief Medications
  • Long-Term Asthma Control Medications

Breakup by Route of Administration:

  • Inhalation
  • Oral
  • Parenteral

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being AstraZeneca, Abbott, Amgen Inc., Biogen Inc., Boehringer Ingelheim GmbH, F. Hoffmann-La Roche AG, GlaxoSmithKline plc., Merck & Co. Inc., Novartis AG, Sunovion Pharmaceuticals Inc. (Dainippon Sumitomo Pharma Co. Ltd.) and Teva Pharmaceutical Industries Ltd.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Asthma Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Anti-Inflammatory Drugs
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Bronchodilators
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Combination Therapies
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Product Type

  • 7.1 Inhalers
    • 7.1.1 Market Trends
    • 7.1.2 Major Types
      • 7.1.2.1 Dry Powder Inhalers
      • 7.1.2.2 Metered Dose Inhalers
      • 7.1.2.3 Soft Mist Inhalers
    • 7.1.3 Market Forecast
  • 7.2 Nebulizers
    • 7.2.1 Market Trends
    • 7.2.2 Major Types
      • 7.2.2.1 Pneumatic Nebulizers
      • 7.2.2.2 Ultrasonic Nebulizers
      • 7.2.2.3 Mesh Nebulizers
    • 7.2.3 Market Forecast

8 Market Breakup by Treatment Type

  • 8.1 Quick-Relief Medications
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Long-Term Asthma Control Medications
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Route of Administration

  • 9.1 Inhalation
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Oral
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Parenteral
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AstraZeneca
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Abbott
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Amgen Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Biogen Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Boehringer Ingelheim GmbH
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 F. Hoffmann-La Roche AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 GlaxoSmithKline Plc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Merck & Co. Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Novartis AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sunovion Pharmaceuticals Inc. (Dainippon Sumitomo Pharma Co. Ltd.)
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 SWOT Analysis
    • 15.3.11 Teva Pharmaceutical Industries Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Asthma Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Asthma Therapeutics Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Asthma Therapeutics Market: Breakup by Drug Class (in %), 2020
  • Figure 4: Global: Asthma Therapeutics Market: Breakup by Product Type (in %), 2020
  • Figure 5: Global: Asthma Therapeutics Market: Breakup by Treatment Type (in %), 2020
  • Figure 6: Global: Asthma Therapeutics Market: Breakup by Route of Administration (in %), 2020
  • Figure 7: Global: Asthma Therapeutics Market: Breakup by Region (in %), 2020
  • Figure 8: Global: Asthma Therapeutics Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 9: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 10: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 11: Global: Asthma Therapeutics (Bronchodilators) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 12: Global: Asthma Therapeutics (Bronchodilators) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 13: Global: Asthma Therapeutics (Combination Therapy) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 14: Global: Asthma Therapeutics (Combination Therapy) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 15: Global: Asthma Therapeutics (Inhalers) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 16: Global: Asthma Therapeutics (Inhalers) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 17: Global: Asthma Therapeutics (Nebulizers) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 18: Global: Asthma Therapeutics (Nebulizers) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 19: Global: Asthma Therapeutics (Quick-Relief Medications) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 20: Global: Asthma Therapeutics (Quick-Relief Medications) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 21: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 22: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 23: Global: Asthma Therapeutics (Inhalation) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 24: Global: Asthma Therapeutics (Inhalation) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 25: Global: Asthma Therapeutics (Oral) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 26: Global: Asthma Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 27: Global: Asthma Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 28: Global: Asthma Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 29: North America: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 30: North America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 31: United States: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 32: United States: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 33: Canada: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 34: Canada: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 35: Asia Pacific: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 36: Asia Pacific: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 37: China: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 38: China: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 39: Japan: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 40: Japan: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 41: India: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 42: India: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 43: South Korea: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 44: South Korea: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 45: Australia: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 46: Australia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 47: Indonesia: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 48: Indonesia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 49: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 50: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 51: Europe: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 52: Europe: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 53: Germany: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 54: Germany: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 55: France: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 56: France: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 57: United Kingdom: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 58: United Kingdom: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 59: Italy: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 60: Italy: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 61: Spain: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 62: Spain: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 63: Russia: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 64: Russia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 65: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 66: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 67: Latin America: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 68: Latin America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 69: Brazil: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 70: Brazil: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 71: Mexico: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 72: Mexico: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 73: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 74: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 75: Middle East and Africa: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 76: Middle East and Africa: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 77: Global: Asthma Therapeutics Industry: SWOT Analysis
  • Figure 78: Global: Asthma Therapeutics Industry: Value Chain Analysis
  • Figure 79: Global: Asthma Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Asthma Therapeutics Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Asthma Therapeutics Market Forecast: Breakup by Drug Class (in Million US$), 2021-2026
  • Table 3: Global: Asthma Therapeutics Market Forecast: Breakup by Product Type (in Million US$), 2021-2026
  • Table 4: Global: Asthma Therapeutics Market Forecast: Breakup by Treatment Type (in Million US$), 2021-2026
  • Table 5: Global: Asthma Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
  • Table 6: Global: Asthma Therapeutics Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 7: Global: Asthma Therapeutics Market Structure
  • Table 8: Global: Asthma Therapeutics Market: Key Players